Please assess the completion status of the following clinical trial:

Trial Title: Study of Asenapine in Elderly Subjects With Psychosis (A7501021)(P05717)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Elderly subjects with psychosis~Exclusion Criteria:~* Have an uncontrolled, unstable clinically significant~medical condition.~* Have an established diagnosis of dementia

- Gender: ALL
- Minimum Age: 65 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Asenapine 2-10 mg BID (Type: EXPERIMENTAL): Dose titration from 2 mg to 5 mg to 10 mg twice daily (BID)
- Asenapine 5-10mg BID (Type: EXPERIMENTAL): Dose titration from 5 mg to 10 mg BID

Based on this trial design, predict the completion outcome and termination type (if applicable).